Vueway (gadopiclenol) receives positive CHMP opinion

Bracco Diagnostics

12 October 2023 - The CHMP of the EMA recommended approval of the macrocyclic, high relaxivity Vueway (gadopiclenol) in adults and paediatric patients older than 2 years of age.

Bracco Imaging today received notification that the CHMP of the EMA has adopted a positive opinion recommending approval of Vueway (gadopiclenol) solution for injection for magnetic resonance imaging for use in adult and paediatric patients aged 2 years and older with magnetic resonance imaging of the CNS (brain, spine, and surrounding tissues) and several body organs (liver, kidney, pancreas, breast, lung, prostate, and musculoskeletal system).

Read Bracco Imaging press release

Michael Wonder

Posted by:

Michael Wonder